Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-25T09:51:50.891Z Has data issue: false hasContentIssue false

“Restless Arms Syndrome” Associated with Olanzapine

Published online by Cambridge University Press:  16 April 2020

G. Konstantakopoulos
Affiliation:
First Department of Psychiatry, University of Athens, Eginition Hospital, Athínai, Greece
P. Oulis
Affiliation:
First Department of Psychiatry, University of Athens, Eginition Hospital, Athínai, Greece
P. Michalopoulou
Affiliation:
Second Department of Psychiatry, University of Athens, Attikon General Hospital, Athínai, Greece Section of Schizophrenia, Imaging and Therapeutics, Department of Psychiatry, Institute of Psychiatry, King's College London, London, UK
G. Papadimitriou
Affiliation:
First Department of Psychiatry, University of Athens, Eginition Hospital, Athínai, Greece

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Restless legs syndrome (RLS) is a common neurological disorder characterized by dysesthetic sensations in the legs and irresistible urge to move them. Arm restlessness has been reported as an accompanying feature in up to 48.7% of patients with RLS, although involvement of upper limbs is rarely reported as an initial symptom of RLS. the term “restless arms syndrome” (RAS) has been proposed for the restlessness of the arms with clinical features similar to RLS. Drug-induced RLS has been described under treatment with various drugs, including the atypical antipsychotics olanzapine, risperidone, quetiapine, and clozapine. However, there are as yet no reports on drug-induced RAS without RLS. We report on the case of a 24-year-old male with chronic paranoid schizophrenia, whereby olanzapine at 10 mg/d induced RAS within 24 hours, however reversible upon its discontinuation. A retrial of olanzapine at 5 mg/d resulted in reemergence of the syndrome, which resolved again when olanzapine was definitely discontinued. Clinicians should be aware of olanzapine's potential to induce RAS and thus be knowledgeable in its differential diagnosis, especially from antipsychotic-induced akathisia.

Type
P03-08
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.